TXMD

THERAPEUTICSMD INC

TXMD·88338N206·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

TXMD (THERAPEUTICSMD INC) is held by 27 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($714,468), RENAISSANCE TECHNOLOGIES LLC ($295,324), MORGAN STANLEY ($261,018). Net institutional sentiment: Mixed.

27
Holders
Avg rating(5 Elite)
$2.2M
Total Value
55% (29)
Fund Consensus
11 buying - 9 selling
TXMDSmart Money Verdict
View all
Held by 27 funds
5 elite
Who's Trading
ActivistBABaselake Partners, LP5.2%Apr 6, 2026
InsiderTGThompson Tommy GBuy $14KDec 23, 2025
InsiderWDWalker Marlan DBuy $489.27Apr 14, 2025
InsiderTGThompson Tommy GBuy $325.58Apr 14, 2025
InsiderWDWalker Marlan DBuy $1KApr 10, 2025
InsiderWDWalker Marlan DBuy $993.66Apr 9, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
353,697$714,4680.0%-9.91%
38
Increased
146,200(+51.5%)$295,3240.0%+17.92%
33
Unchanged
129,217$261,0180.0%+24.45%
0
Decreased
115,145(-0.8%)$232,5930.0%+94.17%
0
Increased
109,817(+3.5%)$221,8840.0%-52.73%
16
Increased
68,314(+141.9%)$137,9940.0%+14.37%
24
New
63,831$128,9390.0%-9.91%
34
Unchanged
30,100$60,8020.0%-11.11%
0
New
27,487$55,5240.0%-9.91%
29
Decreased
21,220(-39.6%)$42,8640.0%+21.95%
0
Decreased
16,093(-2.2%)$32,5080.0%-63.78%
0
New
10,706$21,6260.0%-9.91%
29
New
4,937$9,9730.0%-9.91%
26
Unchanged
610$1,2260.0%-70.17%
0
Decreased
331(-70.3%)$6690.0%+34.54%
0
Unchanged
293$5830.0%+94.17%
0
Unchanged
246$4970.0%-98.63%
0
Unchanged
226$4570.0%+94.02%
0
Decreased
153(-98.3%)$3080.0%+26.57%
0
Unchanged
120$2420.0%-99.18%
0

Showing 1-20 of 29

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used